Zoloft Lawsuit Update: Pretrial Order Establishes Protocol for Selecting Zoloft Lawsuits for Early Bellwether Trials, Bernstein Liebhard LLP Reports

Share Article

The Firm is currently investigating Zoloft birth defect lawsuits on behalf of families whose child was born with a congenital abnormality allegedly associated with their mother’s use of Zoloft during pregnancy.

Bernstein Liebhard LLP | Consumer Injury Lawyers
We are pleased to see this litigation moving forward. Bellwether trials will be important in gauging how juries might rule in similar Zoloft birth defect cases.

Federal Zoloft lawsuits continue to move forward in the multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. According to a Pretrial Order dated January 17th, the Court has established a protocol for selecting Zoloft lawsuits for early bellwether trials. The Order directs the Plaintiffs’ Steering Committee to select 12 Zoloft birth defect claims for inclusion in the Early Discovery Group by February 15th. Attorneys for Pfizer, Inc. have been directed to select 13 cases for the Group by February 25th. (In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation - MDL 2342)

“We are pleased to see this litigation moving forward. Bellwether trials will be important in gauging how juries might rule in similar Zoloft birth defect cases,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Zoloft lawsuit consultations to victims of birth defects allegedly associated with the drug.

Zoloft Birth Defects
Zoloft is a selective serotonin reuptake inhibitor (SSRI) antidepressant used to treat major depression, obsessive-compulsive disorder, panic disorder, and anxiety disorders. As of December 2012, at least 250 Zoloft birth defect cases had been filed in the Pennsylvania litigation. All of the lawsuits allege that use of Zoloft during pregnancy can increase the risk of delivering a child with severe birth defects, including pulmonary hypertension in newborns (PPHN), spina bifida and other neural tube defects, heart defects, abdominal defects, and club foot. Court documents indicate that the first trial in the litigation is tentatively scheduled to begin no later than September 12, 2014. The next status conference in the Zoloft birth defect litigation is scheduled for February 25th, 2013.

Victims of alleged Zoloft side effects may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about alleged Zoloft birth defects, please visit Bernstein Liebhard LLP’s website. For additional information, contact a lawyer at Bernstein Liebhard LLP today by calling (877) 779-1414.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website